aremefentanil

Aremefentanil is an opioid analgesic and mu-opioid receptor agonist mentioned in clinical trial contexts, such as ChiCTR2600121554, for its use in postoperative recovery. It is described as being evaluated in elderly patients undergoing laparoscopic radical colorectal cancer resection, often in conjunction with a transversus abdominis plane (TAP) block, to improve recovery quality and facilitate early mobilization. The drug is compared to other potent opioids like sufentanil. However, there is no evidence of a distinct chemical entity named 'aremefentanil' in pharmacological databases or regulatory records; the name is widely considered a typographical error for the ultra-short-acting opioid remifentanil.

Other names

aremefentanil